Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.05M P/E - EPS this Y 98.50% Ern Qtrly Grth -
Income -49.84M Forward P/E -0.47 EPS next Y 65.70% 50D Avg Chg 133.00%
Sales 11M PEG - EPS past 5Y - 200D Avg Chg -72.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -98.00%
Recommedations 3.00 Quick Ratio 0.46 Shares Outstanding 4.05M 52W Low Chg 350.00%
Insider Own 0.54% ROA -67.64% Shares Float 3.20M Beta 0.12
Inst Own 8.21% ROE - Shares Shorted/Prior 322.97K/277.99K Price 0.24
Gross Margin -283.22% Profit Margin - Avg. Volume 63,756,935 Target Price 8.00
Oper. Margin -753.80% Earnings Date May 21 Volume 286,459,715 Change 54.29%
About T2 Biosystems, Inc.

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood test that identifies blood stream infections that causes sepsis and candidemia; T2Bacteria panel, a direct-from-blood test, which detects bacterial pathogens associated with sepsis; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2SARS-CoV-2 panel to detect SARS-CoV-2 virus. In addition, it is developing T2Biothreat panel for detection of biothreat pathogens; comprehensive sepsis panel to detect bloodstream infections caused by bacterial and Candida species, and antibiotic resistant markers; T2Cauris panel to provide direct detection of the emerging superbug Candida auris in patient skin, patient blood, and hospital environmental samples; and T2Lyme panel, a direct-from-blood test panel designed to run on the T2Dx Instrument to identify the bacteria that cause Lyme disease. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

T2 Biosystems, Inc. News
02/16/24 T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript
02/16/24 Q4 2023 T2 Biosystems Inc Earnings Call
02/15/24 T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
02/15/24 T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity
02/15/24 T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia
02/12/24 T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel
02/07/24 T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024
02/07/24 U.S. Department of Health and Human Services and Steven and Alexandra Cohen Foundation Name T2 Biosystems a Phase 2 Winner in the LymeX Diagnostics Prize
01/18/24 T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients
01/03/24 T2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric Testing
11/03/23 T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
11/01/23 T2 Biosystems Regains Compliance with Nasdaq Listing Requirements
10/24/23 T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference
10/23/23 T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement
10/16/23 T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2023 Earnings Call Transcript
10/13/23 Why Shares of T2 Biosystems Are Falling Friday
10/12/23 T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates
10/12/23 T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii
10/12/23 T2 Biosystems Announces Reverse Stock Split Effective Today
10/06/23 T2 Biosystems Reports Granting of Inducement Award
TTOO Chatroom

User Image Bud1234 Posted - 54 minutes from now

$TTOO @tcamp923 Cautious yes... Nervous no. I will be holding onto my shares. Perhaps adding ? maybe . Think T2's products are cutting edge and most likely the future Gold Standard replacement to Blood Culture testing. Other than Thierry Bernard's departure notice, BOD's membership changes without communication is a concern. Thanks @tcamp for your input I should slow down on the excessive weekend posting. I need to work on that. Sorry my questions troubled you. Was hoping for open discussions. All meant with good intentions.

User Image Bud1234 Posted - 51 minutes from now


User Image Game4bet Posted - 11 minutes from now

$TTOO I hope for big news in this week!

User Image tcamp923 Posted - 4 hours ago

$TTOO if you’re posting on stocktwits 10 times/day asking questions all the time Sell the stock You’re too nervous Sell The Stock If you can’t take the heat, get out of the kitchen Stop asking everyone else to do your DD… some of you need to just buy indices bc your risk tolerance is nowhere close to where it should be if you’re going to be stock picking, let alone speculative biotechs still in late stage R&D… Honest to god stop gambling… And I’m extremely bullish btw.. just can’t stand seeing some of these nervous retail.. go by SPY and stfu lmfao

User Image Bud1234 Posted - 5 hours ago

$TTOO feb 2024 https://www.t2biosystems.com/wp-content/uploads/2024/02/SCCM-2024-Additional-Detections-by-T2B-final.pdf

User Image Bud1234 Posted - 5 hours ago

$TTOO Feb 2024 https://www.sciencedirect.com/science/article/abs/pii/S073288932300216X

User Image NEWBIGTECH Posted - 9 hours ago


User Image NewNewOld Posted - 12 hours ago


User Image Greenenergy33 Posted - 16 hours ago

$TTOO Not less than 400 :D

User Image Bud1234 Posted - 23 hours ago

$TTOO Should this be concerning ? seems T2's CMO and BOD positions maybe revolving seats? Dr Aparna Ahuja a former Chief Medical Officer, T2 Biosystems Inc 2021 to 2023? Since this 2020 list (see attached 2020 BOD PR) . Only 2 BOD Members remain. Is this a standard industry practice ? Other than Thierry Bernard's recent departure cant find BOD PR news. https://investors.t2biosystems.com/news-releases/news-release-details/t2-biosystems-announces-changes-board-directors

User Image elplushies37 Posted - 1 day ago

@SeriouslyFurious well what do we have here? Seriously furious? The lord and savior of $ttoo?🤭🤭🤭 look at him know scavaging the stock market now🤭🤭🤭

User Image Bud1234 Posted - 1 day ago

$TTOO searched Dr. Michael A. Pfaller, tried to confirm if he is currently connected to T2. Other than he served as CMO starting in 2015, I can not find any other info. Any one have info regarding t2's CMO's participation?

User Image Bud1234 Posted - 1 day ago

$TTOO Yesterday I saw that T@ Biosystems was posting for an opening for CMO Chief Medical Officer. This post was not listed in T2's career section.. Today I cannot find the post anywhere on the web??? I searched T2's BOD list_ no CMO listed? Is this normal not to have a CMO in a company like T2 ? Anyone have any info regarding this?

User Image TheGenieOfWallstreet Posted - 1 day ago


User Image Jehovahschild Posted - 1 day ago

$ARDX $AXTI $GNS $ICU $TTOO We’re all making fun of you for letting us all in on your quarrel as if it’s going to be in the Wall Street Journal 😉 Nah just kidding bud, trade however you want, I’m just feeling goofy this Saturday (don’t mind me) Both of you guys are correct in my opinion Timeframes to collect is different though chart traders get the first laugh, DD gets the longer laugh if you’re in a promising company (rare)

User Image LicketySplitz03 Posted - 1 day ago

$TTOO 😎🌴🍹🌴

User Image TheGenieOfWallstreet Posted - 1 day ago

$ICU $TTOO $AXTI $GNS $ARDX This guy is trying to make fun of me for saying “trade charts not your opinions.” This industry needs education.

User Image Bud1234 Posted - 1 day ago

$TTOO posted job openings 2_24_24 for T2 (6 openings, with 1 contract basis for manufacturing) , Danaher Diagnostics (146 openings) and Fischer Scientific Instr. (148 openings Boston Area) Appears T2 maybe in a Holding Pattern?

User Image Notabagman Posted - 1 day ago

$AXTI $GLT $ICU $LUNR $TTOO exactly, not buying NBY and def not selling ICU to buy NBY but thanks Genie ICU is more

User Image Health_Be_Wealth Posted - 1 day ago

$AXTI $GLT $ICU $LUNR $TTOO Buy Low Sell High 🤣🤑🎉 💎 TTOO 💎

User Image Ovolee Posted - 1 day ago

$AXTI $GLT $ICU $LUNR $TTOO lol that’s what ur doin with the NBY lol

User Image TheGenieOfWallstreet Posted - 1 day ago

$ICU $TTOO $GLT $AXTI $LUNR If anyone else wants to join a group with genuine education about penny stocks not just “buy this company bc it’s the next Jesus Christ”, the invite link is in this message. Lmk if it doesn’t work and I can send you another. I’ll teach you how to out think all these people staring at the word gullible on the ceiling.💙

User Image TheGenieOfWallstreet Posted - 1 day ago

GM.☕️ # 1 Rule of penny stocks, don’t believe the hype, trade the hype. I used to be on a management team and I will tell you, every companies management teams’ number one job is to make it seem like their company is the next best thing so that they can raise money. It’s not rocket science you just have to realize this and trade the hype that they create, don’t join the people (sheep) that think they just found the needle in the haystack. And Warrent Buffet quotes about buying when there’s blood in the streets applies to large cap stocks not penny stocks on the verge of delisting. Use your brains! I know all of you have the capabilities to learn how management teams use gullible retail looking to get rich to raise money. I’m here to change the penny game so that WE get rich not these clever management teams, and that’s exactly what I’m gonna do.💙 $ICU $TTOO $ANY $BETS $HOLO

User Image VMAESA Posted - 1 day ago

$TTOO I warned y’all clowns👇 What did you learn?

User Image NEWBIGTECH Posted - 1 day ago

$ICU $ESPR Lutnick, CEO of Cantor Fitzgerald, says that the big growth moves will be in Medical technology over the next 3years. Biotech will be where the growth is. Maria Bartiromo. WALL STREET. On fox business. $ICU , $FEMY , $TTOO $SLS . all winners

User Image NEWBIGTECH Posted - 1 day ago

$ESPR Lutnick, CEO of Cantor Fitzgerald, says that the big growth moves will be in Medical technology over the next 3years. Biotech will be where the growth is. Maria Batgirl mom's WALL STREET. On fox business. $ICU , $FEMY , $TTOO $SLS . all winners

User Image tcamp923 Posted - 1 day ago

$TTOO hopium for these ICU “investors” Straight. Hopium.

User Image the_viking Posted - 1 day ago

$ICU Next week will really be interesting. PM on monday will show if that was a gameplay and money is coming back in. The FDA Hype is gone and many retails got burned. So if it rises, that should be by people buying who where behind the crash in the first place to get cheap shares. I sold, as a "long", and I´m happy I did. My long changed to Swing. So I bought back in yesterday under 0.80 and could snatch some at 0.56 in AM too and was green after 10min. But I´m honest.. I didnt bought as many as I had in the first place... I´m still afraid they do the $TTOO and release a Reverse Split soon. Why? They want the Bride to look good when the enter the market to get the eyes of some bigger whales, and the only way they can do that now is by R/S. So I will keep my finger on the sell button all the time.

User Image 911AXX Posted - 1 day ago

$TTOO 10+? When?

User Image Alongapojoe2 Posted - 2 days ago

@LRaye $TTOO

Analyst Ratings
Alliance Global Partners Neutral Jul 13, 23
Alliance Global Partners Neutral Jan 24, 23
Canaccord Genuity Hold Oct 14, 22
Alliance Global Partners Neutral Jul 7, 22
BTIG Neutral Jul 7, 22
Alliance Global Partners Buy Feb 18, 22
Alliance Global Partners Neutral Jan 27, 21
SVB Leerink Outperform Jan 27, 21
Canaccord Genuity Buy Nov 5, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Giffin Brett A. Chief Commercial Off.. Chief Commercial Officer Feb 20 Sell 0.65 537 349 3,049 11/28/23
CR Group L.P. 10% Owner 10% Owner Sep 27 Sell 0.17 13,130,147 2,232,125 09/29/23
CR Group L.P. 10% Owner 10% Owner Sep 25 Sell 0.25 250,000 62,500 5,021,014 09/27/23
CR Group L.P. 10% Owner 10% Owner Sep 22 Sell 0.26 5,079,344 1,320,629 5,088,781 09/26/23
CR Group L.P. 10% Owner 10% Owner Sep 21 Sell 0.3 6,338,211 1,901,463 6,465,629 09/25/23
CR Group L.P. 10% Owner 10% Owner Sep 20 Sell 0.31 7,753,710 2,403,650 8,183,716 09/22/23
Gibbs Michael Terrence General Counsel General Counsel Mar 28 Sell 0.481 239 115 6,612 04/06/23
Sperzel John J III Chairman, CEO, and P.. Chairman, CEO, and President Apr 07 Buy 0.50 30,000 15,000 221,773 04/11/22
Barclay Alec Chief Operations Off.. Chief Operations Officer Apr 08 Buy 0.50 12,952 6,476 181,945 04/11/22
Gibbs Michael Terrence General Counsel General Counsel Apr 07 Buy 0.49 10,000 4,900 166,651 04/11/22
Sprague John M Chief Financial Offi.. Chief Financial Officer Apr 08 Buy 0.4767 10,000 4,767 152,350 04/11/22
Giffin Brett A. Chief Commercial Off.. Chief Commercial Officer Apr 08 Buy 0.489 10,600 5,183 10,600 04/11/22